Abstract:Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by the extracellular amyloid plaques in the brain. Recent studies have shown that ferroptosis, a recently identified cell death pathway associated with the accumulation of lipid hydroperoxides, is closely related to the occurrence and exacerbation of AD. The application of ferroptosis inhibitors can alleviate the development of AD in both cellular and animal models. Herein, a series of dual-functional hydroxylated chalcone derivatives by integrating the heterocyclic dimethylaminopyrimidine in the core structure were designed and synthesized beyond our previous research to optimize their inhibition activities towards A beta protein aggregation and ferroptosis simultaneously. The inhibitory ability of the novel synthesized chalcone derivatives were greatly improved. The results indicated that the introduction of the dimethylaminopyrimidine structure provided improved effect on A beta protein aggregation inhibitory activity in both solution and cellular models. Trihydroxy chalcone derivative A-N-5 provided the best inhibition activities against A beta protein aggregation in cellular models. The trihydroxy compound A-N-5 did not show cytotoxicity at the concentration lower than 100 mu M (with IC50 > 1 mM), but had a significant effect on promoting cell proliferation. Results indicated that compound A-N-5 could potentially promote neuronal cell growth in the damaged brain tissue. The compound could also inhibit ferroptosis induced by RSL or erastin and reduce the lipid peroxidation levels induced by A beta(1-42) protein aggregation. Molecular docking was also conducted to explain the better inhibitory effect of novel compounds to inhibit A beta protein aggregation compared to the previous designed molecules without incorporation of the dimethylaminopyrimidine. In summary, the trihydroxy compound A-N-5 showed the best inhibition activities against A beta aggregation as well as ferroptosis with low cytotoxicity as a promising molecular skeleton candidate for further development of lead compound for in vivo test to treat AD.

Ferrocene tripeptide Gly-Pro-Arg conjugates: synthesis and inhibitory effects on Alzheimer's Aβ(1-42) fibrillogenesis and Aβ-induced cytotoxicity in vitro

Ferrocene Tripeptide Gly-Pro-Arg Conjugates: Synthesis and Inhibitory Effects on Alzheimer’s Aβ1–42 Fibrillogenesis and Aβ-induced Cytotoxicity in Vitro

Synthesis and Evaluation of Ferrocenoyl Pentapeptide (Fc-Klvff) As an Inhibitor of Alzheimer’s Aβ1–42 Fibril Formation in Vitro

Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro

Synthesis and Biological Evaluation of Deferiprone-Resveratrol Hybrids As Antioxidants, Aβ1–42 Aggregation Inhibitors and Metal-Chelating Agents for Alzheimer's Disease

Synthesis of Ferrocenoyl-Peptide and Its Inhibition for Beta-Amyloid Peptide

Synthesis and properties of Ferrocene-modified Aβ inhibitor

Kinetic Studies of Inhibition of the Amyloid Beta (1–42) Aggregation Using a Ferrocene-Tagged Β-Sheet Breaker Peptide

Design, synthesis and evaluation of novel ferulic acid derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease

Molecular Mechanism of Cyanidin-3-O-Glucoside Disassembling Aβ Fibril in Silico

Rational Design of Dual-Functionalized Gd@C82 Nanoparticles to Relieve Neuronal Cytotoxicity in Alzheimer's Disease Via Inhibition of Aβ Aggregation.

Rational Design, Synthesis and Activities of Hydroxylated Chalcones As Highly Potent Dual Functional Agents Against Alzheimer's Disease.

Pharmacodynamics in Alzheimer's Disease Model Rats of a Bifunctional Peptide with the Potential to Accelerate the Degradation and Reduce the Toxicity of Amyloid Β-Cu Fibrils.

Study of the Kinetics and Mechanism of Ferrocene-Tripeptide Inhibiting Insulin Aggregation.

Hybrid molecules synergistically mitigate ferroptosis and amyloid-associated toxicities in Alzheimer's disease

Nanocomposites Facilitate the Removal of Aβ Fibrils for Neuroprotection

Studies of the Interaction Between Aβ Peptides and Carbon Nano-Materials

Molecular Integrative Study on Inhibitory Effects of Pentapeptides on Polymerization and Cell Toxicity of Amyloid-β Peptide (1–42)

On the Role of Synthesized Hydroxylated Chalcones As Dual Functional Amyloid-Β Aggregation and Ferroptosis Inhibitors for Potential Treatment of Alzheimer's Disease.

Self-Assembled Curcumin-Poly(carboxybetaine Methacrylate) Conjugates: Potent Nano-Inhibitors Against Amyloid Β-Protein Fibrillogenesis and Cytotoxicity.

A Ferrocene‐Tagged Amyloid‐β Fragment for Rapid Screening of Aggregation Inhibitors from Natural Compounds by HPLC‐Electrochemical Detection